Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Lancet Oncol. 2021 Nov;22(11):e474-e487. doi: 10.1016/S1470-2045(21)00492-7.
The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015 highlighted potential interventions that could advance cancer care in the region by overcoming existing challenges. Areas requiring improvement included insufficient investment in cancer control, non-universal health coverage, fragmented health systems, inequitable concentration of cancer services, inadequate registries, delays in diagnosis or treatment initiation, and insufficient palliative services. Progress has been made in key areas but remains uneven across the region. An unforeseen challenge, the COVID-19 pandemic, strained all resources, and its negative effect on cancer control is expected to continue for years. In this Series paper, we summarise progress in several aspects of cancer control since 2015, and identify persistent barriers requiring commitment of additional resources to reduce the cancer burden in Latin America and the Caribbean.
癌症负担不断增加是拉丁美洲和加勒比地区面临的一个重大问题。2013 年和 2015 年的两份《柳叶刀肿瘤学》专刊重点强调了一些潜在的干预措施,这些措施可以通过克服现有挑战来推进该地区的癌症护理。需要改进的领域包括:癌症控制投资不足、非全民健康覆盖、分散的卫生系统、癌症服务分布不均、登记处不足、诊断或治疗启动延迟以及姑息治疗服务不足。该地区在一些关键领域已经取得了进展,但进展仍不平衡。新冠疫情这一意料之外的挑战使所有资源都承受了压力,预计其对癌症控制的负面影响将持续多年。在本系列论文中,我们总结了自 2015 年以来癌症控制几个方面的进展,并确定了需要投入更多资源以减少拉丁美洲和加勒比地区癌症负担的持续存在的障碍。